Search by Drug Name or NDC
NDC 00299-5935-75 AKLIEF 50 ug/g Details
AKLIEF 50 ug/g
AKLIEF is a TOPICAL CREAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Galderma Laboratories, L.P.. The primary component is TRIFAROTENE.
MedlinePlus Drug Summary
Trifarotene is used to treat acne in adults and children 9 years of age and older. Trifarotene is in a class of medications called retinoids. It works by promoting peeling of affected skin areas, unclogging pores, and preventing new pimples from forming under the skin.
Related Packages: 00299-5935-75Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Trifarotene Topical
Product Information
| NDC | 00299-5935 |
|---|---|
| Product ID | 0299-5935_a867cb7a-4d96-4e98-8a65-dd74ba71704f |
| Associated GPIs | 90050035003720 |
| GCN Sequence Number | 080265 |
| GCN Sequence Number Description | trifarotene CREAM (G) 0.005 % TOPICAL |
| HIC3 | L9B |
| HIC3 Description | VITAMIN A DERIVATIVES |
| GCN | 46989 |
| HICL Sequence Number | 046048 |
| HICL Sequence Number Description | TRIFAROTENE |
| Brand/Generic | Brand |
| Proprietary Name | AKLIEF |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | trifarotene |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | ug/g |
| Substance Name | TRIFAROTENE |
| Labeler Name | Galderma Laboratories, L.P. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA211527 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00299-5935-75 (00299593575)
| NDC Package Code | 0299-5935-75 |
|---|---|
| Billing NDC | 00299593575 |
| Package | 1 BOTTLE, PUMP in 1 CARTON (0299-5935-75) / 75 g in 1 BOTTLE, PUMP |
| Marketing Start Date | 2019-10-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |